XML 118 R105.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation - Summary of Stock Options Activity (Detail) - Share-Based Payment Arrangement, Option [Member] - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
2019 Equity Incentive Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Stock Options, Granted 0  
2022 Equity Incentive Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Stock Options, Outstanding, December 31, 2021 421,500  
Number of Stock Options, Granted 94,500  
Number of Stock Options, Expired/terminated (14,000)  
Number of Stock Options, Exercised (12,000)  
Number of Stock Options, Outstanding, December 31, 2022 490,000 421,500
Number of Stock Options, Exercisable at period end 208,700  
Weighted- Average Exercise Price, Outstanding, December 31, 2021 $ 10.46  
Weighted- Average Exercise Price, Granted 9.00  
Weighted- Average Exercise Price, Expired/terminated 11.00  
Weighted- Average Exercise Price, Exercised 10.00  
Weighted- Average Exercise Price, Outstanding, December 31, 2022 10.11 $ 10.46
Weighted- Average Exercise Price, Exercisable at period end $ 10.15  
Weighted- Average Remaining Contractual Term, Balance 7 years 1 month 6 days 7 years 10 months 24 days
Weighted- Average Remaining Contractual Term, Granted 9 years 3 months 18 days  
Weighted- Average Remaining Contractual Term, Expired/terminated 8 years 1 month 6 days  
Weighted-Average Remaining Contractual Term, Balance 7 years 1 month 6 days 7 years 10 months 24 days
Weighted- Average Remaining Contractual Term, Exercisable at period end 6 years 6 months  
Aggregate Intrinsic Value, Outstanding, December 31, 2021 $ 780  
Aggregate Intrinsic Value, Granted $ 33  
Aggregate Intrinsic Value, Outstanding, December 31, 2022 $ 33 $ 780
Aggregate Intrinsic Value, Exercisable at period end $ 0